Anticancer effects of suberoylanilide hydroxamic Acid (SAHA) in esophageal squamous cell carcinoma

被引：0
|
作者：
Tzao, Ching
Chen, Ban-Hen
Hsu, Ting-Yun
Sun, Guang-Huan
Chiou, Shi-Hwa
Lee, Shih-Chun
机构：
[1] Natl Def Med Ctr, Triserv Gen Hosp, Taipei, Taiwan
[2] Vet Gen Hosp, Taipei, Taiwan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4613
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo
    Tzao, C.
    Jin, J-S
    Chen, B-H
    Chung, H-Y
    Chang, C-C
    Hsu, T-Y
    Sun, G-H
    [J]. DISEASES OF THE ESOPHAGUS, 2014, 27 (07) : 693 - 702
  • [2] Histone deacetylator (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA) sensitizes squamous carcinoma cells of lung to pemetrexed
    Kim, Soyeon
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Heo, Dae Seog
    [J]. CANCER RESEARCH, 2011, 71
  • [3] The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
    Chen, Shuo
    Zhao, Yang
    Gou, Wen-feng
    Zhao, Shuang
    Takano, Yasuo
    Zheng, Hua-chuan
    [J]. PLOS ONE, 2013, 8 (11):
  • [4] In vitro effects of the combination of idarubicin (IDA) with suberoylanilide hydroxamic acid (SAHA) or valproic acid (VPA) in leukemia cell lines.
    Sanchez-Gonzalez, B
    Hoshino, K
    Bueso-Ramos, C
    Yang, H
    Youssef, E
    Boumber, Y
    Santos-Malave, C
    Garcia-Manero, G
    [J]. BLOOD, 2004, 104 (11) : 332A - 332A
  • [5] Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines
    Shen, Jun
    Huang, Canhua
    Jiang, Lu
    Gao, Feng
    Wang, Zhi
    Zhang, Yuanyuan
    Bai, Jingping
    Zhou, Hongmei
    Chen, Qianming
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 73 (12) : 1901 - 1909
  • [6] Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
    Futakuchi, Akiko
    Inoue, Toshihiro
    Fujimoto, Tomokazu
    Kuroda, Utako
    Inoue-Mochita, Miyuki
    Takahashi, Eri
    Ohira, Saori
    Tanihara, Hidenobu
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (04) : 2421 - 2429
  • [7] Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid
    Rikiishi, Hidemi
    Shinohara, Fumiaki
    Sato, Tomonori
    Sato, Yoshitaro
    Suzuki, Maiko
    Echigo, Seishi
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (05) : 1181 - 1188
  • [8] The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma
    Ghayad, Sandra E.
    Rammal, Ghina
    Sarkis, Omar
    Basma, Hussein
    Ghamloush, Farah
    Fahs, Assil
    Karam, Mia
    Harajli, Mohamad
    Rabeh, Wissam
    Mouawad, Joe E.
    Zalzali, Hassan
    Saab, Raya
    [J]. CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 272 - 283
  • [9] Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines
    Yamamoto, Shunsaku
    Tanaka, Kazuhiro
    Sakimura, Riku
    Okada, Takamitsu
    Nakamura, Tomoyuki
    Li, Yan
    Takasaki, Minoru
    Nakabeppu, Yusaku
    Iwamoto, Yukihide
    [J]. ANTICANCER RESEARCH, 2008, 28 (3A) : 1585 - 1591
  • [10] Suberoylanilide Hydroxamic Acid (SAHA) Is a Driver Molecule of Neuroplasticity: Implication for Neurological Diseases
    Verrillo, Lucia
    Di Palma, Rosita
    de Bellis, Alberto
    Drongitis, Denise
    Miano, Maria Giuseppina
    [J]. BIOMOLECULES, 2023, 13 (09)
12345